What does pharmaceutical-grade 10% niacinamide with 1% zinc achieve in the acid mantle?
A 2% formulation of pharmaceutical niacinamide reduces sebum oxidation within fourteen days without drying the skin barrier, while our standardized 10% concentration inhibits lipid peroxidation and reinforces stratum corneum ceramides. Offered exclusively on an inquiry-only basis from our Portland facility.
What are the verified chemical assay specifications of this formulation?
Every batch consists of USP-grade nicotinamide (purity ≥99.4%) combined with zinc pyrrolidone carboxylic acid (zinc PCA) at exactly 1.0% by weight.
Nicotinamide (Vitamin B3) functions as a cellular precursor to the coenzymes NAD+ and NADP+, directly fueling adenosine triphosphate synthesis across basal keratinocytes. In clinical trials, excessive sebum excretion creates an oxidative environment that triggers localized perifollicular inflammation. The addition of 1% zinc PCA inhibits 5-alpha reductase activity while providing natural antimicrobial astringency without drying epidermal bilayers.
| Active Component A | Niacinamide (Nicotinamide) USP 10.00% w/w (±0.15%) |
| Active Component B | Zinc Pyrrolidone Carboxylic Acid (Zinc PCA) 1.00% w/w |
| Base Vehicle Matrix | Deionized Aqua, Propanediol, Ethoxydiglycol, Tamarindus Indica Seed Polysaccharide |
| Calibrated pH Value | 6.02 at 22°C (Buffer: Citric acid / Triethyl citrate) |
| Molecular Weight Matrix | 122.12 g/mol (Niacinamide) | 321.60 g/mol (Zinc PCA) |
| Container Engineering | Amber borosilicate Type I glass, fluoroelastomer bulb, calibrated glass pipette |
| Preservation Profile | Caprylyl glycol, Phenoxyethanol (0.6%), Hydroxyacetophenone |
How does amber borosilicate glass prevent active degradation?
Amber borosilicate glass vials block 99.2% of photo-degradative light, preserving sensitive topical solutions against nicotinic acid conversion.
When aqueous niacinamide is exposed to sunlight or short-wavelength indoor radiation below pH 5.0, it hydrolyzes into nicotinic acid. Free nicotinic acid triggers intense cutaneous vasodilation, producing immediate erythema and severe facial flushing. We engineer our solution to remain stable at pH 6.0 and store it exclusively in thick-walled Type I amber glass bottles. The pipette mechanism dispenses exactly 0.05 ml per drop, eliminating product contamination and formulation wastage.
Typical market alternatives utilize transparent flint glass bottles to showcase clear liquid aesthetics. We refuse this compromise because photolytic decay reduces raw active efficacy by up to 24% over sixty days of ambient shelf exposure.
Complete optical attenuation across ultraviolet B (280–315nm) and ultraviolet A (315–400nm) spectrums.
Borosilicate glass formula exhibits zero alkali leaching into the aqueous vehicle over a 36-month test period.
Calibrated medical pipette allows clinical practitioners to administer exact drop dosages without skin contact.
Vial headspace undergoes inert nitrogen displacement immediately prior to automated mechanical capping.
Who validates the chemical stability and batch logs of this serum?
Product Manager Irina Petrova has audited batch composition and packaging stability for Alchemii product lines since 2021.
Working from our Portland validation facility at 224 Southwest 1st Avenue, Irina oversees analytical testing on every production lot. Stability verification includes accelerated thermal stress cycles (45°C at 75% relative humidity for 90 days), centrifuge phase-integrity testing at 4,000 g, and digital benchtop electrode pH auditing.
Our corporate registration in Florida and active trade association standing obligate us to document analytical purity for every chemical assay. Stranger-verifiable proof: every wholesale or clinical shipment ships with a signed Certificate of Analysis (CoA) matching the etched laser batch identifier on the bottle base.
What clinical objections and contraindications must practitioners know?
This 10% active serum is contraindicated for individuals experiencing unbuffered topical L-ascorbic acid exposure or active open eczema lesions.
While niacinamide and pure vitamin C can theoretically be applied within the same daily routine, mixing high-concentration 10% niacinamide directly with pure acidic ascorbic acid (below pH 3.5) forms a 1:1 hydrogen-bonded molecular complex. This interaction temporarily reduces the immediate bioavailability of both molecules. We recommend alternating applications: L-ascorbic acid topicals in morning regimens, followed by 10% Niacinamide + Zinc 1% in evening protocols.
Furthermore, this product is not formulated for consumers seeking fragrant sensory elixirs. We add zero synthetic perfumes, masking agents, or artificial colorants. The clear viscous finish and mild natural zinc scent reflect pure pharmaceutical chemistry.
How do you request allocation for this 10% niacinamide formulation?
Submit your packaging and volume requirements below to receive confirmed pricing between $33 and $58 USD per 30ml amber dropper unit.
Portland Formulation Desk
Direct Facility Contact & Allocation Verification
224 Southwest 1st Avenue
Portland, Oregon 97204
United States
Florida Registration & Trade Association Member
Price basis: 33–58 USD / unit